Translational research

The director of our Cancer Research UK Edinburgh Centre walks us through some of his proudest research achievements and how supporters have made them possible.

Cancer Research UK and Hummingbird Bioscience announce a partnership to develop anti-HER3 antibody drug for the treatment of people with HER3 driven cancer

Cancer Research UK is partnering with two of Europe’s leading cancer research charities to fund six international projects worth a total of around £30 million.

The Zika virus can target and kill a particular type of brain tumour cell in the lab.

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Advances in MRI technology could help scientists and doctors tailor cancer treatment by measuring the oxygen levels inside tumours.

Cancer Research UK has announced the largest investment to date into its network of Centres across the UK.

Here are our highlights from day 3 of the NCRI Cancer Conference, including personalised treatment for prostate cancer, and new surgery tech.

Our scientists in Cambridge have developed a specialised camera that could help detect precancerous changes that may develop into oesophageal cancer.

We investigate organoids, the latest way that scientists are growing cancer cells in the lab to help test hundreds of cancer drugs.